Clinical T
This input is used for staging
Notes
**Note 1:** Intraluminal or intramural extension to esophagus and duodenum is classified by the depth of greatest invasion in any of these sites, including stomach. * For extension to esophagus or duodenum via serosa, assign T4b **Note 2:** Assign T2 If the diagnosis states linitis plastica and no other information regarding extension is available. * Linitis plastica is defined as diffuse involvement of the entire thickness of the stomach wall **Note 3:** Assign T4b for contiguous extension from the site of origin. Discontinuous involvement is coded in M (distant metastasis). * *Exception*: Assign T1 for implants within the stomachNAACCR Item
NAACCR #940Clinical T | Clinical T Display | Description | Registrar Notes |
---|---|---|---|
cX | cTX | Primary tumor cannot be assessed | Clinical classification criteria met, evaluation done: Physician unable to assess T Extension cannot be determined Physician assigns cTX, no other information available to determine T |
c0 | cT0 | No evidence of primary tumor | |
pIS | pTis | Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria High grade dysplasia |
Noninvasive (Adeno)carcinoma, noninvasive, in a polyp Stated as Tis |
c1 | cT1 | Tumor invades lamina propria, muscularis mucosae, or submucosa | Note: T1 has subcategories of T1a and T1b. Assign T1 only when there is no information available to assign one of the subcategories Confined to: Head of polyp, NOS Stalk of polyp, NOS Invasive tumor in polyp, NOS Implants inside stomach Localized, NOS Stated as T1 [NOS] |
c1A | cT1a | Tumor invades lamina propria or muscularis mucosae | Invasive tumor confined to mucosa, NOS, including intramucosal, NOS Mucosal tumor with intraluminal extension to esophagus or duodenum Stated as T1a |
c1B | cT1b | Tumor invades submucosa | Superficial invasion of submucosa Submucosal tumor with intraluminal extension to esophagus or duodenum Stated as T1b |
c2 | cT2 | Tumor invades muscularis propria | Invades into but not through muscularis propria Linitis plastica and no other information regarding extension available Invasion of muscularis propria with intraluminal extension to esophagus or duodenum Stated as T2 |
c3 | cT3 | Tumor invades subserosa | Extension through wall, NOS Invasion through muscularis propria or muscularis, NOS Perimuscular tissue invaded Subserosal tissue/(sub)serosal fat invaded Invasion through muscularis propria with intraluminal extension to esophagus or duodenum Extension to adjacent (connective) tissue WITHOUT perforation of visceral peritoneum covering these structures: Gastric artery Ligaments: Gastrocolic Gastrohepatic Gastrosplenic Omentum, NOS : Greater Lesser Perigastric fat Stated as T3 |
c4 | cT4 | Tumor perforates serosa OR Invades adjacent structures |
Note: T4 has subcategories of T4a and T4b. Assign T4 only when there is no information available to assign one of the subcategories Stated as T4 [NOS] |
c4A | cT4a | Tumor perforates serosa | Invasion of/through serosa (mesothelium) (tunica serosa) (visceral peritoneum), including perforation of visceral peritoneum covering the gastric ligaments or the omentum Stated as T4a |
c4B | cT4b | Tumor invades adjacent structures | Adjacent structures include: Abdominal wall Adrenal (suprarenal) gland Aorta Celiac axis Diaphragm Duodenum via serosa Duodenum, NOS Esophagus via serosa Ileum Jejunum Kidney Liver Pancreas Retroperitoneum Small intestine, NOS Spleen Transverse colon/mesocolon (including flexures) Further contiguous extension Stated as T4b |
88 | 88 | Not applicable | Primary site/histology not TNM defined Death certificate only (DCO) case |
<BLANK> | BLANK | See Registrar Notes | Clinical classification criteria not met Clinical classification criteria met, evaluation done: No information about diagnostic workup Results not documented in record Clinical evaluation of primary tumor not done or unknown if done Tumor first detected on surgical resection (no clinical workup) Evidence of metastatic disease [(cM1) or (pM1)], no other workup Only Clinical Stage Group documented (no T, N, or M information available) |